Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users

Journal of Oral Pathology and Medicine

Volumn 36, Issue 7, 2007, Pages 409-414

  Tu, Hsi Feng ^a   Wu, Cheng Hsien ^a,b   Kao, Shou Yen ^a,b   Liu, Chung Ji ^a,c   Liu, Tsung Yun ^d   Lui, Man Tin ^a,b,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Veterans General Hospital   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

MMP 9; Mouth; Oral squamous cell carcinoma; Polymorphism; RFLP; Risk

Indexed keywords

GELATINASE B; GENOMIC DNA;

ADULT; AGED; ARTICLE; BETEL NUT; BLOOD CELL; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CHEEK MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; FIBROSIS; GENE FREQUENCY; GENOTYPE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARECA; CARCINOMA, SQUAMOUS CELL; CYTOSINE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; THYMINE; TRANSCRIPTION, GENETIC;

EID: 34447128785     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00552.x     Document Type: Article

References (45)

1. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003 92 : 827 39.
2. Farias E, Ranuncolo S, Cresta C et al. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer 2000 89 : 389 94.
3. Blankenberg S, Rupprecht HJ, Poirier O et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003 107 : 1579 85.
4. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998 78 : 687 98.
5. Gueders MM, Foidart JM, Noel A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006 533 : 133 44.
6. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 2002 3 : 409 21.
7. Tayebjee MH, Lip GY, MacFadyen RJ. Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. Curr Med Chem 2005 12 : 917 25.
8. Lee PH, Chang MC, Chang WH et al. Prolonged exposure to arecoline arrested human KB epithelial cell growth: regulatory mechanisms of cell cycle and apoptosis. Toxicology 2006 220 : 81 9.
9. Hirakawa S, Lange EM, Colicigno CJ, Freedman BI, Rich SS, Bowden DW. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients. Am J Kidney Dis 2003 42 : 133 42.
10. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 1999 105 : 418 23.
11. Ito I, Nagai S, Handa T et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 2005 172 : 1378 82.
12. Morgan AR, Zhang B, Tapper W, Collins A, Ye S. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med 2003 81 : 321 6.
13. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 2004 24 : 1479 84.
14. Jones GT, Phillips VL, Harris EL, Rossaak JI, van Rij AM. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003 38 : 1363 7.
15. Okamoto K, Mimura K, Murawaki Y, Yuasa I. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 2005 20 : 1102 8.
16. Lichtinghagen R, Bahr MJ, Wehmeier M et al. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci (Lond) 2003 105 : 373 82.
17. Helbecque N, Hermant X, Cottel D, Amouyel P. The role of matrix metalloproteinase-9 in dementia. Neurosci Lett 2003 350 : 181 3.
18. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999 274 : 21491 4.
19. Matsumura S, Oue N, Nakayama H et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 2005 131 : 19 25.
20. Grieu F, Li WQ, Iacopetta B. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 2004 88 : 197 204.
21. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 2002 95 : 1902 10.
22. Department of Health EY, R.O.C. Ranking of cancer mortality in Taiwan. Taiwan : Department of Health EY, R.O.C, 2005.
23. Department of Health EY, R.O.C. Cancer registry annual report in Taiwan area. Taiwan : Department of Health EY, R.O.C, 2002.
24. IARC. Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines. IARC Monogr Eval Carcinog Risks Hum volume 2004 85 : 39.
25. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995 24 : 450 3.
26. Lai KC, Lee TC. Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts. Mutat Res 2006 599 : 66 75.
27. Dasgupta R, Saha I, Pal S et al. Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline in albino mice. Toxicology 2006 227 : 94 104.
28. Liu SY, Lin MH, Yang SC et al. Increased expression of matrix metalloproteinase-2 in oral cells after short-term stimulation and long-term usage of areca quid. J Formos Med Assoc 2005 104 : 390 7.
29. Cao ZG, Li CZ. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 2006 42 : 32 8.
30. Clark AG. The role of haplotypes in candidate gene studies. Genet Epidemiol 2004 27 : 321 33.
31. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995 73 : 209 15.
32. Pollanen PJ, Lehtimaki T, Mikkelsson J et al. Matrix metalloproteinase3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. Atherosclerosis 2005 180 : 73 8.
33. Bindhu OS, Ramadas K, Sebastian P, Pillai MR. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 2006 28 : 916 25.
34. Moon SK, Cha BY, Lee YC et al. Age-related changes in matrix metalloproteinase-9 regulation in cultured mouse aortic smooth muscle cells. Exp Gerontol 2004 39 : 123 31.
35. Moon SK, Cha BY, Kim CH. In vitro cellular aging is associated with enhanced proliferative capacity, G1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells. Arch Biochem Biophys 2003 418 : 39 48.
36. Dunne AA, Sesterhenn A, Gerisch A, Teymoortash A, Kuropkat C, Werner JA. Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract. Anticancer Res 2003 23 : 2233 9.
37. Dunne AA, Grobe A, Sesterhenn AM, Barth P, Dalchow C, Werner JA. Influence of matrix metalloproteinase 9 (MMP-9) on the metastatic behavior of oropharyngeal cancer. Anticancer Res 2005 25 : 4129 34.
38. Wiegand S, Dunne AA, Muller HH et al. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer 2005 104 : 94 100.
39. Demacq C, de Souza AP, Machado AA, Gerlach RF, Tanus-Santos JE. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects. Clin Chim Acta 2006 365 : 183 7.
40. Mannello F. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma. Cancer 2003 97 : 201 3.
41. Ranuncolo SM, Matos E, Loria D et al. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma. Cancer 2002 94 : 1483 91.
42. George J, Patal S, Wexler D, Roth A, Sheps D, Keren G. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure. Am Heart J 2005 150 : 484 7.
43. Dragutinovic VV, Radovanovic NS, Izrael-Zivkovic LT, Vrvic MM. Detection of gelatinase B activity in serum of gastric cancer patients. World J Gastroenterol 2006 12 : 105 9.
44. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Letter 2006 243 : 47 54.
45. Lin SC, Chen YJ, Kao SY et al. Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 2002 38 : 266 73.